LIN vs NDRA
Linde plc Ordinary Shares (LIN) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
NDRA does not have a complete income-statement cache yet.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the LIN and NDRA stock pages for the full models.
Not investment advice.